Konrad H. Stopsack

Related Links

Biography

I am a molecular and clinical epidemiologist with a focus on cancer epidemiology and a background as a board-certified internal medicine physician. My main research interest is how potentially modifiable exposures cause solid tumors through genomic heterogeneity and influence cancer progression. I am passionate about combining well-defined observational studies and state-of-the-art genomics in order to guide cancer prevention and treatment. My methodologic and teaching interests include application and further development of epidemiologic methods for high-dimensional biomarker studies and clinical studies.

Education and Training

• MD, Medicine
  University of Freiburg
• MPH, Biostatistics and Epidemiology
  Harvard School of Public Health
• Residency, Board certification, Internal Medicine
  Mayo Clinic
• Postdoctoral training, Cancer Epidemiology
  Memorial Sloan Kettering Cancer Center

Publications

• Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer.

  Stopsack KH, Vijai J, Conry M, Berchuck JE, Kemel Y, Vasselman SE, Freeman DA, Lee GM, Mandelker D, Solit DB, Morris MJ, Penney KL, Abida W, Offit K, Mucci LA, Kantoff PW, Pomerantz MM. Clin Cancer Res 2024 Oct 25

• Intratumoral vitamin D signaling and lethal prostate cancer.

  Vaselkiv JB, Shui IM, Grob ST, Ericsson CI, Giovannucci I, Peng C, Finn SP, Mucci LA, Penney KL, Stopsack KH. Carcinogenesis 2024 Oct 10

• Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.

  Lenis AT, Ravichandran V, Brown S, Alam SM, Katims A, Truong H, Reisz PA, Vasselman S, Nweji B, Autio KA, Morris MJ, Slovin SF, Rathkopf D, Danila D, Woo S, Vargas HA, Laudone VP, Ehdaie B, Reuter V, Arcila M, Berger MF, Viale A, Scher HI, Schultz N, Gopalan A, Donoghue MTA, Ostrovnaya I, Stopsack KH, Solit DB, Abida W. Clin Cancer Res 2024 Sep 03

• RAD21 promotes oncogenesis and lethal progression of prostate cancer.

  Su XA, Stopsack KH, Schmidt DR, Ma D, Li Z, Scheet PA, Penney KL, Lotan TL, Abida W, DeArment EG, Lu K, Janas T, Hu S, Vander Heiden MG, Loda M, Boselli M, Amon A, Mucci LA. Proc Natl Acad Sci U S A 2024 Sep 03

• Coffee, Phosphoinositide 3-Kinase Signaling Pathway, and Prostate Cancer: A Prospective Study in the Health Professionals Follow-Up Study.

  Song R, Stopsack KH, Ren J, Mucci LA, Clinton SK, Loda M, Wang M, Giovannucci EL, Wilson KM, Smith-Warner SA. J Acad Nutr Diet 2024 Jul 04